PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets) For Patients
See risks & benefits. Learn about PAXLOVID™, an oral Rx that helps stop mild-to-moderate COVID-19 from becoming severe in adults with a high risk factor.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 561.355 |
| 2025-03 | 231.501 |
| 2025-04 | 66.009 |
| 2025-05 | 58.112 |
| Source | Traffic Share |
|---|---|
| search | 52.26% |
| direct | 33.59% |
| referrals | 6.66% |
| paid referrals | 5.55% |
| social | 1.90% |
| 0.05% |
| Region | Percentage |
|---|---|
| United States | 90.52% |
| Australia | 4.45% |
| United Kingdom | 2.50% |
| Canada | 1.43% |
| India | 1.09% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| paxlovid | 25,235 | 252,350 | $1.92 |
| paxlovid for covid | 388 | 3,880 | $4.57 |
| paxlovid side effects | 4,681 | 46,810 | $0.44 |
| paxlovid voucher pap | 5 | 50 | $0.00 |
| paxlovid benefits risks | 8 | 80 | $0.00 |